LONDON, Oct. 12, 2016 /PRNewswire/ -- The healthcare industry is steadily realizing the value offered by Big Data solutions, particularly in "-omics" research and medical record mining. However, current investments are focused on serving immediate needs of the investing stakeholders, which often makes them siloed and incrementally beneficial, as opposed to a strategic organizational redesign of the data strategy that provides exponential returns on investment. Industry participants, including governments, payers, providers, suppliers and consumers, must develop Big Data strategies with clear goals to improve specific processes, such as patient engagement, clinical decision making, population health/risk management, and outcomes improvement. This is crucial to achieve the future vision of a patient-centric, predictive and prescriptive healthcare system.
Growth Opportunities for Healthcare Big Data—An Analysis of Global Case Studies is part of Frost & Sullivan's Connected Health Growth Partnership Service program.
For complimentary access to more information on this research, please visit: http://frost.ly/wh
"Globally, healthcare is moving towards value-based, preventive models of care, albeit at varying degrees across countries," said Transformational Health Research Analyst Natasha Gulati. "In the next five years, a number of countries in Europe and Asia-Pacific will adopt care models that reward clinicians for improving long-term patient outcomes, particularly for chronic diseases, rather than volume of care delivered. This change in key performance indicators will necessitate better data aggregation, analytics, and compliance from clinicians."
In its recent analysis of this evolving market, Frost & Sullivan assesses a large set of healthcare Big Data case studies to identify stakeholders and segments that will present attractive opportunities for Big Data solutions going forward. Case studies include:
An increasingly data-empowered clinical workforce and consumer base are demanding on-the-go data analytics to better manage care. While consumer and end-user interest is high, a critical missing element at an enterprise level is a change management strategy which goes beyond training clinicians on Big Data tools.
"The value of health data lies in meaningfully integrating and analyzing structured and unstructured health data so that it helps clinicians develop unprecedented approaches and solutions to real-world problems," noted Gulati. "Change management driven from within by opinion leaders, and in collaboration with IT decision makers, will create a strong drive towards Big Data management and analytics in the next five years."
Ultimately, the goal is to make healthcare more predictive and prescriptive through meaningful information and insights. The primary areas of Big Data and analytics application will be Population Health Management (PHM), Clinical Decision Support (CDS), and real-world data. By 2020, the global healthcare big data and analytics market revenue is expected to reach $7.50 billion with the Americas leading, Europe catching up fast, and Asia a distant third.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.
Contact us: Start the discussion
Growth Opportunities for Healthcare Big Data -- An Analysis of Global Case Studies
9AB9
Contact:
Jana Schoneborn
Corporate Communications -- Europe
P: +49(0)69-77033-43
E: jana.schoeneborn@frost.com
Photo - http://photos.prnasia.com/prnh/20161012/8521606527
